12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Endocet oxycodone/acetaminophen regulatory update

Novartis disclosed in its 3Q12 earnings that the restart of commercial production at the pharma's Lincoln, Neb., manufacturing facility is taking longer than originally anticipated. Novartis said it is unlikely that it...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >